Cargando…

Survival of patients newly diagnosed with colorectal cancer and with a history of previous cancer

Patients with previous cancer are often excluded from clinical trials despite limited evidence about their prognosis. We examined the effect of previous cancer on overall and colorectal cancer (CRC)‐specific survival of patients newly diagnosed with CRC. This population‐based cohort study from the U...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pruitt, Sandi L., Gerber, David E., Zhu, Hong, Heitjan, Daniel F., Maddineni, Bhumika, Xiong, Danyi, Singal, Amit G., Tavakkoli, Anna, Halm, Ethan A., Murphy, Caitlin C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8290226/ https://www.ncbi.nlm.nih.gov/pubmed/34190429 http://dx.doi.org/10.1002/cam4.4036

Ejemplares similares

Survival of cancer survivors with a new pancreatic cancer diagnosis
por: Pruitt, Sandi L., et al.
Publicado: (2022)

Regional and racial variations in the utilization of endoscopic retrograde cholangiopancreatography among pancreatic cancer patients in the United States
por: Tavakkoli, Anna, et al.
Publicado: (2019)

Revisiting a longstanding clinical trial exclusion criterion: impact of prior cancer in early-stage lung cancer
por: Pruitt, Sandi L, et al.
Publicado: (2017)

Colorectal Cancer Screening and Yield in a Mailed Outreach Program in a Safety-Net Healthcare System
por: Murphy, Caitlin C., et al.
Publicado: (2021)

Closing the gap: Contribution of surgical best practices to outcome differences between high‐ and low‐volume centers for lung cancer resection
por: von Itzstein, Mitchell S., et al.
Publicado: (2020)

Revisiting Exclusion of Prior Cancer in Clinical Trials of Male Breast Cancer
por: Rathod, Aniruddha, et al.
Publicado: (2023)

Efficacy and Safety of Bevacizumab-Containing Therapy in Newly Diagnosed Ovarian Cancer: ROSiA Single-Arm Phase 3B Study
por: Oza, Amit M., et al.
Publicado: (2017)

Prognostic value of quantitative fluorodeoxyglucose measurements in newly diagnosed metastatic breast cancer
por: Ulaner, Gary A, et al.
Publicado: (2013)

Machine learning for the prediction of bone metastasis in patients with newly diagnosed thyroid cancer
por: Liu, Wen‐Cai, et al.
Publicado: (2021)

Preexisting morbidity profile of women newly diagnosed with breast cancer in sub‐Saharan Africa: African Breast Cancer—Disparities in Outcomes study
por: Ayeni, Oluwatosin A., et al.
Publicado: (2020)

Long‐term survival benefit of upfront chemotherapy in patients with newly diagnosed borderline resectable pancreatic cancer
por: Shrestha, Bikram, et al.
Publicado: (2017)

Treatment‐related mortality in newly diagnosed pediatric cancer: a population‐based analysis
por: Gibson, Paul, et al.
Publicado: (2018)

The risk of early mortality in elderly patients with newly diagnosed acute myeloid leukemia
por: Liu, Chia‐Jen, et al.
Publicado: (2020)

Risk factors and predictors of lymph nodes metastasis and distant metastasis in newly diagnosed T1 colorectal cancer
por: Guo, Kaibo, et al.
Publicado: (2020)

Association of US County-Level Eviction Rates and All-Cause Mortality
por: Rao, Shreya, et al.
Publicado: (2022)

Establishing a research agenda for early-onset colorectal cancer
por: Murphy, Caitlin C., et al.
Publicado: (2018)

The Role of Cytoreductive Radical Prostatectomy in the Treatment of Newly Diagnosed Low-volume Metastatic Prostate Cancer. Results from the Local Treatment of Metastatic Prostate Cancer (LoMP) Registry
por: Lumen, Nicolaas, et al.
Publicado: (2021)

Clinical comparisons between previously diagnosed SLE and newly diagnosed SLE by kidney biopsy
por: Tonsawan, Pantipa, et al.
Publicado: (2020)

Pathology-confirmed versus non pathology-confirmed cancer diagnoses: incidence, participant characteristics, and survival
por: van der Willik, Kimberly D., et al.
Publicado: (2019)

Is fluoride a risk factor for bone cancer? Small area analysis of osteosarcoma and Ewing sarcoma diagnosed among 0–49-year-olds in Great Britain, 1980–2005
por: Blakey, Karen, et al.
Publicado: (2014)

Family history of gastric mucosal abnormality and the risk of gastric cancer: a population-based observational study
por: Song, Huan, et al.
Publicado: (2018)

Expression and function of SLC38A5, an amino acid-coupled Na(+)/H(+) exchanger, in triple-negative breast cancer and its relevance to macropinocytosis
por: Ramachandran, Sabarish, et al.
Publicado: (2021)

Clinical significance of granule‐containing myeloma cells in patients with newly diagnosed multiple myeloma
por: Suzuki, Kazuhito, et al.
Publicado: (2016)

Changes in conditional net survival and dynamic prognostic factors in patients with newly diagnosed metastatic prostate cancer initially treated with androgen deprivation therapy
por: Narita, Shintaro, et al.
Publicado: (2019)

Predicting cancer risk based on family history
por: Jacobs, Michelle F
Publicado: (2021)

Stool-Based Tests Mitigate Impacts of COVID-19 on Colorectal Cancer Screening
por: Liu, Po-Hong, et al.
Publicado: (2023)

2163 Polypharmacy and patterns of prescription medication use among cancer survivors
por: Murphy, Caitlin, et al.
Publicado: (2018)

Newly diagnosed and previously treated multicentric Castleman disease respond equally to siltuximab
por: van Rhee, Frits, et al.
Publicado: (2020)

The outcomes of newly diagnosed elderly multiple myeloma patients treated at a single U.S. institution
por: Bonomo, Lauren, et al.
Publicado: (2016)

Mortality of Pregnancy Following Breast Cancer Diagnoses in Taiwanese Women
por: Chuang, Shu‐Chun, et al.
Publicado: (2019)

A new prognostic score for disease progression and mortality in patients with newly diagnosed primary CNS lymphoma
por: Liu, Chia‐Jen, et al.
Publicado: (2020)

Levetiracetam as a sensitizer of concurrent chemoradiotherapy in newly diagnosed glioblastoma: An open‐label phase 2 study
por: Hwang, Kihwan, et al.
Publicado: (2021)

Health services utilization, out‐of‐pocket expenditure, and underinsurance among insured non‐elderly cancer survivors in the United States, 2011–2015
por: Karim, Mohammad A., et al.
Publicado: (2021)

Non-participation in breast cancer screening among previous cancer patients
por: Virgilsen, Line Flytkjær, et al.
Publicado: (2018)

Maintenance therapy for newly diagnosed epithelial ovarian cancer– a review
por: Nag, Shona, et al.
Publicado: (2022)

Clinical Significance of Systemic Inflammation Markers in Newly Diagnosed, Previously Untreated Hepatocellular Carcinoma
por: Yu, Jeong Il, et al.
Publicado: (2020)

Molecular natural history of breast cancer: Leveraging transcriptomics to predict breast cancer progression and aggressiveness
por: Cook, Daniel J., et al.
Publicado: (2020)

Hypercalcemia caused by humoral effects and bone damage indicate poor outcomes in newly diagnosed multiple myeloma patients
por: Bao, Li, et al.
Publicado: (2020)

Clinical outcomes of newly diagnosed primary CNS lymphoma treated with ibrutinib‐based combination therapy: A real‐world experience of off‐label ibrutinib use
por: Chen, Feili, et al.
Publicado: (2020)

Family history of breast cancer and its association with disease severity and mortality
por: Melvin, Jennifer C., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_uft6pgq2m8cbdhpahtgt98pbit